Developer of genomics medicines via technology powered by artificial intelligence (AI)
Whitelab Genomics has raised €9.8M across 1 funding round from 2 investors, most recently a Series A round in Sep 2022. Based in Paris, France; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-09-13 | Series A | €9.8M |
| Debiopharm Innovation Fund,Omnes Capital |
| View deal → |
